Spectral AI Reports Latest US Government Contract

March 12, 2024

DENVER, Colo., Mar 12, 2024 (247marketnews.com)- Spectral AI, Inc. (NASDAQ:MDAI) stated, this morning, that it was awarded a new contract with the Defense Health Agency (DHA) and the US Army Medical Material Development Activity (USAMMDA), which provides significant additional support for the development of the DeepView SnapShot handheld wound imaging system.

MDAI is trading at $1.93, up $0.21 (+12.21%), on 7.9M shares.

The latest contract is valued at over $500,000 and adds to the previously announced non-dilutive financial support from the US Government, which now totals over $250 million, including $150 million awarded in the last six months.

“Spectral AI is proud to partner with DHA and the USAMMDA on this crucial initiative. This award further validates Spectral AI’s technology and the importance of a battlefield burn solution we are focusing on,” stated Pete Carlson, CEO of Spectral AI. “We firmly believe that this collaboration will make a profound impact, as the miniaturization of medical devices is essential for introducing innovative medical care to a wider range of clinical settings and patients. This development reaffirms Spectral AI’s dedication to shaping the future of accessible medical care and solidifies its position as a trailblazer in AI-driven healthcare innovation.”

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (MDAI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.